Research
Hormonal
Semaglutide 2.4 mg use is associated with significant side effects, including gastrointestinal distress and rare but severe complications like pancreatitis.
Be prepared for gastrointestinal side effects, especially when starting or increasing the dose. These often subside, but severe symptoms like pancreatitis require immediate medical attention.
ModerateSupportsMEDIUM confidence
Users discussed experiencing a variety of side effects with semaglutide 2.4 mg, including gastrointestinal discomfort, nausea, diarrhea, constipation, headaches, and fatigue... some users described significant health complications attributed to semaglutide 2.4 mg use, such as episodes of severe constipation leading to emergency room visits, gallbladder issues, abdominal pain, appendicitis, and pancreatitis.
Why this rating
Based on qualitative self-reports from social media.
Source
A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss
Eion Plenn et al. · Obesity Science & Practice · 2025
DOI 10.1002/osp4.70085
cross_sectional · n=660Cited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →